Abo Bibliothek: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review

Volumen 35, Ausgabe 3, 2018, pp. 195-292
DOI: 10.1615/CritRevTherDrugCarrierSyst.2018019429
Get accessGet access

ABSTRAKT

Pancreatic cancer (PC) is one of the most fatal solid tumors, resulting in more than 250,000 deaths per year globally. It is the eighth leading cause of death from cancer in men and women throughout the world and is now third leading cause of cancer-related deaths in the United States. In addition, the worldwide occurrence of PC ranges from 1 to 10 cases per 100,000 people, indicating a higher incidence in developed countries. Most patients with locally advanced or metastatic disease are not candidates for curative resection due to enormously poor prognosis. Substantial efforts have been taken during the past decade to distinguish better treatments in the absence of efficient screening methods. Regardless of wide-ranging efforts, various systems and therapies have shown insufficient efficacy for PC patients. Therefore, the development of novel drug delivery systems, strategies, and diverse therapeutic approaches to improve the range of active molecules for the treatment of PC is critical. Currently, cancer research focuses on improving the treatment of PC via diverse novel drug delivery systems of chemotherapeutic agents. These novel drug delivery systems consist of nanoparticles and liposomes. Strategies or therapeutic approaches intended for PC include radiation therapy, ablation therapy, and gene therapy. These systems and approaches can carry the drug molecules to targeted cancer cells to enhance the effectiveness of tumor penetration. The present review encloses existing novel drug carrier systems and approaches for PC management.

REFERENZIERT VON
  1. Pang Juan, Gao Ziyu, Tan Huaping, Mao Xincheng, Xu Jialing, Kong Jingyang, Hu Xiaohong, Fabrication, Investigation, and Application of Light-Responsive Self-Assembled Nanoparticles, Frontiers in Chemistry, 7, 2019. Crossref

  2. Hashemzadeh Alireza, Drummen Gregor P. C., Avan Amir, Darroudi Majid, Khazaei Majid, Khajavian Ruhollah, Rangrazi Abdolrasoul, Mirzaei Masoud, When metal–organic framework mediated smart drug delivery meets gastrointestinal cancers, Journal of Materials Chemistry B, 9, 19, 2021. Crossref

  3. Nedelcu Andreea, Mocan Teodora, Grapa Cristiana, Mocan Lucian, Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic Cancer, International Journal of Molecular Sciences, 22, 15, 2021. Crossref

  4. Hani Umme, Osmani Riyaz Ali M., Siddiqua Ayesha, Wahab Shadma, Batool Sadia, Ather Hissana, Sheraba Norhan, Alqahtani Ali, A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer, Journal of Drug Delivery Science and Technology, 63, 2021. Crossref

  5. Bhaskaran Mahendran, Devegowda Vishakante Gowda, Gupta Vishal Kumar, Shivachar Amruthesh, Bhosale Rohit Rajendra, Arunachalam Muthuraman, Vaishnavi Thirumalaraju, Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme, ACS Chemical Neuroscience, 11, 19, 2020. Crossref

  6. Furtado Fernando Augusto de Souza, Escobar Jhon Fernando Berrı́o, Martinez Alejandro Martinez, Giordani Cristiano, Caiut José Maurício Almeida, Caseli Luciano, Molina Celso, Molecular Information on the Potential of Europium Complexes for Local Recognition of a Nucleoside-Based Drug by Using Nanostructured Interfaces Assembled as Langmuir–Blodgett Films, Langmuir, 36, 14, 2020. Crossref

  7. Ashour Amira S., Guo Yanhui, Mohamed Waleed S., Clinical applications of thermal ablation, in Thermal Ablation Therapy, 2021. Crossref

  8. Honarvari Banafsheh, Karimifard Sara, Akhtari Niyayesh, Mehrarya Mehrnoush, Moghaddam Zahra Salehi, Ansari Mohammad Javed, Jalil Abduladheem Turki, Matencio Adrián, Trotta Francesco, Yeganeh Faten Eshrati, Farasati Far Bahareh, Arki Mandana Kazem, Naimi-Jamal Mohammad Reza, Noorbazargan Hassan, Lalami Zahra Asghari, Chiani Mohsen, Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study, Molecules, 27, 14, 2022. Crossref

  9. Moghtaderi Maryam, Sedaghatnia Kamand, Bourbour Mahsa, Fatemizadeh Mahdi, Salehi Moghaddam Zahra, Hejabi Faranak, Heidari Fatemeh, Quazi Sameer, Farasati Far Bahareh, Niosomes: a novel targeted drug delivery system for cancer, Medical Oncology, 39, 12, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain